Best treatments for supraventricular tachycardia
16 products may treat supraventricular tachycardia, spanning FDA drug classes such as antiarrhythmic, calcium channel blocker, beta-adrenergic blocker. The current highest-rated option is propafenone hydrochloride. Ranked below by our independent recall-safety rating (rated where FDA data exists) — not medical advice; always consult a professional.
Quick answer: Of the 16 drugs we list for supraventricular tachycardia, 12 are available as lower-cost generics, spanning classes such as antiarrhythmic, calcium channel blocker, beta-adrenergic blocker. They’re ranked by each drug’s FDA recall-safety record — not clinical effectiveness for supraventricular tachycardia — so confirm the right choice with your prescriber.
Understanding supraventricular tachycardia
"Tachycardia, Supraventricular" is an umbrella label, not a single disease. The 2015 ACC/AHA/HRS guideline defines SVT as tachycardia with atrial and/or ventricular rates above 100 bpm at rest arising from tissue in the His bundle or above, and lists what belongs in the bucket: inappropriate sinus tachycardia, focal and multifocal atrial tachycardia, typical atrial flutter, junctional tachycardia, AVNRT, and accessory-pathway tachycardias (the Wolff-Parkinson-White family). One exclusion trips people up: atrial fibrillation sits above the ventricles too, but that guideline states the term SVT does not generally include AF, which is covered by a separate AF guideline. The same guideline puts SVT prevalence at 2.29 per 1000 persons, with roughly 89,000 new cases of paroxysmal SVT a year and 570,000 people living with it; women have twice the risk of men of developing PSVT, and people over 65 more than five times the risk of younger people. StatPearls (NCBI Bookshelf) notes the ECG signature is a narrow QRS complex under 120 ms, and the guideline says a 12-lead ECG recorded during the tachycardia — and again in sinus rhythm — is what may reveal the mechanism, which is why capturing a tracing during an episode matters. What gets missed: the guideline reports a study in which panic-disorder criteria were met by 67% of patients whose SVT went unrecognized at first evaluation, and physicians attributed the symptoms to panic, anxiety, or stress in 54%, with women more likely than men to be mislabeled. This is general information, not medical advice.
First-line treatment
According to the 2015 ACC/AHA/HRS guideline for adult SVT, vagal maneuvers (Valsalva, carotid sinus massage) carry a Class I recommendation for acute treatment of regular SVT and are described as the first-line intervention; adenosine is likewise Class I, and synchronized cardioversion is Class I when the patient is hemodynamically unstable and vagal maneuvers or adenosine are ineffective or not feasible, and also Class I in stable patients when drug therapy is ineffective or contraindicated. Intravenous diltiazem or verapamil is Class IIa in hemodynamically stable patients. For ongoing management, the guideline gives Class I to oral beta blockers, diltiazem, or verapamil - explicitly in patients who do not have ventricular pre-excitation during sinus rhythm - and Class I to an electrophysiology study with the option of ablation. It warns that patients given diltiazem or verapamil when the rhythm is really pre-excited AF (or ventricular tachycardia) may become hemodynamically unstable or have an accelerated ventricular rate.
Top-rated picks for supraventricular tachycardia: 1. Propafenone Hydrochloride · 2. Verapamil Hydrochloride · 3. Verelan
| # | Drug | Rating | Type | Form | Class | Generic? | Pharmacy pays | |
|---|---|---|---|---|---|---|---|---|
| 1 | 72/100 | Prescription | Capsule | Antiarrhythmic | Generic | $11 | View → | |
| 2 | 70/100 | Prescription | Injectable | Calcium Channel Blocker | Generic | $6 | View → | |
| 3 | 70/100 | Prescription | Capsule | Calcium Channel Blocker | Generic | $6 | View → | |
| 4 | 70/100 | Prescription | Capsule | Calcium Channel Blocker | Generic | $6 | View → | |
| 5 | 68/100 | Prescription | Injectable | Antiarrhythmic | Generic | $4 | View → | |
| 6 | Not yet rated | Prescription | Tablet | Antiarrhythmic | Generic | $3 | View → | |
| 7 | Not yet rated | Prescription | Tablet | Antiarrhythmic | Generic | $3 | View → | |
| 8 | Not yet rated | Prescription | Injectable | beta-Adrenergic Blocker | No data | — | View → | |
| 9 | Not yet rated | Prescription | Injectable | beta-Adrenergic Blocker | No data | — | View → | |
| 10 | Not yet rated | Prescription | Spray/Inhaler | — | No data | — | View → |
Narrow by drug class
Explore the class hubs: antiarrhythmic · calcium channel blocker · beta-adrenergic blocker
Full ranking · 16 treatments
propafenone hydrochloride
Boxed warningPrescriptionFDA-sourced
Propafenone Hydrochloride is an antiarrhythmic used to treat Atrial Fibrillation, Supraventricular Tachycardia.
Pharmacy pays
From ~$3.34/30· 6 forms Save up to 72% in classverapamil hydrochloride
PrescriptionFDA-sourced
Verapamil Hydrochloride is a calcium channel blocker used to treat Variant Angina Pectoris, Atrial Fibrillation, Atrial Flutter, Hypertension.
Pharmacy pays
From ~$2.22/30· 8 forms Save up to 94% in classverelan
PrescriptionFDA-sourced
Verelan (Verapamil Hydrochloride) is a calcium channel blocker used to treat Variant Angina Pectoris, Atrial Fibrillation, Atrial Flutter, Hypertension.
Pharmacy pays
From ~$2.22/30· 8 forms Save up to 94% in classverelan pm
PrescriptionFDA-sourced
Verelan Pm (Verapamil Hydrochloride) is a calcium channel blocker used to treat Variant Angina Pectoris, Atrial Fibrillation, Atrial Flutter, Hypertension.
Pharmacy pays
From ~$2.22/30· 8 forms Save up to 94% in classamiodarone hydrochloride
PrescriptionFDA-sourced
Amiodarone Hydrochloride is an antiarrhythmic used to treat Supraventricular Tachycardia, Ventricular Fibrillation.
Pharmacy pays
From ~$3.60/30· 4 forms Save up to 19% in classbetapace
Boxed warningPrescriptionFDA-sourced
Betapace (Sotalol Hydrochloride) is an antiarrhythmic used to treat Atrial Fibrillation, Atrial Flutter, Supraventricular Tachycardia, Ventricular Fibrillation.
Pharmacy pays
From ~$2.08/30· 4 forms- Betapace Af
- Brevibloc
- Brevibloc Double Strength in Plastic Container
- Cardamyst
- Cardizem Cd
- Cardizem La
- Nexterone
- Rapiblyk
- Sorine
- Tiazac
Frequently asked
- What treats supraventricular tachycardia?
- Our catalog lists 16 products that may treat supraventricular tachycardia, based on NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. They're rated where FDA recall-safety data exists; the current top-rated option is propafenone hydrochloride.
- What is the best-rated treatment for supraventricular tachycardia?
- By our independent recall-safety rating — not an efficacy measure — propafenone hydrochloride ranks highest among the products we list for supraventricular tachycardia. Always consult a professional.
- How are these treatments ranked?
- By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.
- What types of drugs treat supraventricular tachycardia?
- Treatments for supraventricular tachycardia span FDA drug classes including antiarrhythmic, calcium channel blocker, beta-adrenergic blocker. Compare every option side by side, ranked by independent rating, above.
Treatment associations are derived from NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. This is general reference, not medical advice — always consult a licensed professional.
Sources
The clinical overview above is written from these authoritative public-health and medical-society sources, independently reviewed against each.
- 2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia (Circulation) ↗
- Supraventricular Tachycardia - StatPearls, NCBI Bookshelf ↗
- Paroxysmal supraventricular tachycardia - MedlinePlus (NLM) ↗
- Guideline for the Management of Adult Patients with Supraventricular Tachycardia: Top Things to Know (AHA Professional) ↗